Frazier Management as of Dec. 31, 2020
Portfolio Holdings for Frazier Management
Frazier Management holds 35 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics (ARQT) | 22.8 | $297M | 11M | 28.13 | |
| Phathom Pharmaceuticals (PHAT) | 14.9 | $194M | 5.8M | 33.22 | |
| Passage Bio | 9.9 | $128M | 5.0M | 25.57 | |
| Tarsus Pharmaceuticals (TARS) | 6.1 | $79M | 1.9M | 41.33 | |
| Mirum Pharmaceuticals (MIRM) | 4.8 | $62M | 3.6M | 17.46 | |
| Vaxcyte (PCVX) | 4.7 | $61M | 2.3M | 26.57 | |
| Iovance Biotherapeutics (IOVA) | 4.7 | $61M | 1.3M | 46.40 | |
| Krystal Biotech (KRYS) | 4.1 | $54M | 895k | 60.00 | |
| Trillium Therapeutics Com New | 3.5 | $45M | 3.1M | 14.70 | |
| Translate Bio | 3.1 | $40M | 2.2M | 18.43 | |
| Alpine Immune Sciences | 2.5 | $32M | 2.6M | 12.60 | |
| Syndax Pharmaceuticals (SNDX) | 2.4 | $31M | 1.4M | 22.24 | |
| Sutro Biopharma (STRO) | 1.7 | $22M | 1.0M | 21.71 | |
| Anaptysbio Inc Common (ANAB) | 1.5 | $19M | 900k | 21.50 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.5 | $19M | 944k | 20.03 | |
| Iveric Bio | 1.3 | $17M | 2.5M | 6.91 | |
| Frazier Lifesciences Acqu Unit 12/09/2025 | 1.2 | $16M | 1.5M | 10.38 | |
| Adverum Biotechnologies | 1.2 | $16M | 1.4M | 10.84 | |
| Regenxbio Inc equity us cm (RGNX) | 1.2 | $16M | 342k | 45.36 | |
| Aptinyx | 0.9 | $11M | 3.2M | 3.46 | |
| Cardiff Oncology (CRDF) | 0.8 | $10M | 569k | 17.99 | |
| Freeline Therapeutics Hldgs Sponsored Ads | 0.8 | $10M | 550k | 18.26 | |
| Rocket Pharmaceuticals (RCKT) | 0.7 | $9.2M | 168k | 54.84 | |
| Gritstone Oncology Ord (GRTSQ) | 0.6 | $8.1M | 2.1M | 3.94 | |
| Epizyme | 0.6 | $7.9M | 731k | 10.86 | |
| Molecular Templates | 0.6 | $7.9M | 842k | 9.39 | |
| Scholar Rock Hldg Corp (SRRK) | 0.6 | $7.4M | 154k | 48.53 | |
| Allena Pharmaceuticals | 0.3 | $4.3M | 3.3M | 1.28 | |
| Bellus Health Com New | 0.3 | $3.9M | 1.3M | 3.01 | |
| Sierra Oncology Com New | 0.3 | $3.3M | 203k | 16.03 | |
| Galera Therapeutics (GRTX) | 0.2 | $2.5M | 241k | 10.23 | |
| Silverback Therapeutics (SPRY) | 0.1 | $1.7M | 36k | 46.35 | |
| Iterum Therapeutics SHS | 0.1 | $1.5M | 1.5M | 0.99 | |
| Nabriva Therapeutics Shs New | 0.1 | $1.0M | 426k | 2.42 | |
| Minerva Neurosciences | 0.0 | $144k | 62k | 2.34 |
